Dr. Victoria Findlay is an Associate Professor in the Department of Surgery and Co-Leader of the Cancer Prevention & Control Program at the NCI-designated Massey Comprehensive Cancer Center at Virginia Commonwealth University. She earned her BSc in Edinburgh, Scotland, and her PhD in Genetics at the University of Newcastle, England.

Dr. Findlay has dedicated her career to advancing women’s health and inspiring the next generation of scientists. Her research focuses on advanced glycation end products (A.G.E.s) – dietary metabolites with growing evidence of impact on cancer development and progression. She and her colleagues have uncovered significant links between A.G.E. metabolites and aggressive cancer outcomes, contributing to new understanding of how modifiable exposures may reduce cancer risk and improve disease management. Her investigations into the role of A.G.E.s in normal breast development highlight critical “windows of susceptibility” throughout a woman’s life that may influence breast cancer risk.

Beyond the laboratory, Dr. Findlay is deeply committed to public health education. Recognizing the importance of reaching diverse audiences, she co-founded the Anti-A.G.E.s Foundation, a nonprofit dedicated to raising global awareness of A.G.E.s and their health implications. Through this initiative, she and her team engage patients, community members, clinicians, and healthcare professionals with practical knowledge to empower informed health decisions and promote cancer prevention.

Through her combined efforts in research, education, and community engagement, Dr. Findlay is advancing a vision of healthier futures not only for women but for all individuals—bridging scientific discovery with real-world impact.